Acadia Pharmaceuticals
1,054 employees on LinkedIn · 1 known investors
Find your way into Acadia Pharmaceuticals
Acadia is a biopharmaceutical company developing therapies for underserved neurological disorders and rare diseases. The company operates across North America and Europe, leveraging expertise in areas including Parkinson's disease psychosis and Rett syndrome.
Investors · 1
Frequently asked questions
- What does Acadia Pharmaceuticals do?
- Acadia is a biopharmaceutical company developing therapies for underserved neurological disorders and rare diseases. The company operates across North America and Europe, leveraging expertise in areas including Parkinson's disease psychosis and Rett syndrome.
- Who are Acadia Pharmaceuticals's investors?
- Acadia Pharmaceuticals's investors include New Enterprise Associates (NEA).